✦ LIBER ✦

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

✍ Scribed by Charles A. Kunos; Michael W. Sill; Thomas E. Buekers; Joan L. Walker; Jeanne M. Schilder; S. Diane Yamada; Steven E. Waggoner; Mohammed Mohiuddin; Paula M. Fracasso

Book ID: 113962658
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 165 KB
Volume: 120
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.10.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Bevacizumab in Persist

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

A phase II evaluation of mifepristone in

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Sequence dependence of hematologic toxic

Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

✍ Michael A. Bookman; D. Scott McMeekin; Paula M. Fracasso 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Docetaxel plus trabectedin appears activ

Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: A phase II study of the Gynecologic Oncology Group

✍ Maurie Markman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Docetaxel plus trabectedin appears activ

Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

✍ Bradley J. Monk; Michael W. Sill; Parviz Hanjani; Robert Edwards; Jacob Rotmensc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 285 KB

A Phase I Study of Weekly Cisplatin and

A Phase I Study of Weekly Cisplatin and Whole Abdominal Radiation for the Treatment of Stage III and IV Endometrial Carcinoma: A Gynecologic Oncology Group Pilot Study

✍ Susan A. Reisinger; Robert Asbury; Shu-Yuan Liao; Howard D. Homesley 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 68 KB